Oncology Learning Network

In deiner App anhören

• Podcast Index
• RSS

Folgen

191 Folgen

1. Artificial Intelligence Advances Lymphoma Diagnosis, Biomarker Identification, and Precision Treatment vor 1 Woche 5:17
2. Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice vor 1 Monat 10:57
3. Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice vor 1 Monat 12:28
4. Immune Checkpoint Inhibition in Advanced cSCC: Perspectives From Clinical Practice vor 2 Monaten 13:58
5. Preparing for Biomarker-Directed Care in epNEC: What Pathologists Need to Know Now vor 3 Monaten 12:28
6. Artificial Intelligence for Skin Cancer Diagnosis vor 3 Monaten 11:57
7. Beyond FVC: What FIBRONEER-ILD Means for Outcomes, Patients, and Access in PPF vor 4 Monaten 17:10
8. Real-World Decision Points in Biomarker-Driven NSCLC Management vor 4 Monaten 5:17
9. Connecting the Dots: How MET Fits Into Comprehensive Molecular Profiling vor 4 Monaten 3:56
10. Testing Matters: Practical Approaches to Biomarker Evaluation in NSCLC vor 4 Monaten 6:47
11. Tafasitamab Plus Lenalidomide Improves Frontline Outcomes in High-Risk Diffuse Large B-Cell Lymphoma vor 4 Monaten 6:30
12. When to Raise the Question of CAR T–Cell Therapy in Multiple Myeloma vor 5 Monaten 8:50
13. Closing the Gap Between CAR T–Cell Therapy Recognition and Referral in Multiple Myeloma vor 5 Monaten 13:03
14. Olverembatinib Plus Blinatumomab Produces Deep Responses in Ph+ Acute Lymphoblastic Leukemia vor 5 Monaten 3:44
15. How is ctDNA MRD Testing Used in Lymphoma Care? vor 5 Monaten 9:11
16. How Are We Detecting Residual Disease in Lymphoma Today? vor 5 Monaten 8:48
17. How Are We Detecting Residual Disease in Lymphoma Today? vor 5 Monaten 8:59
18. Treatment of Recurrent Refractory Pediatric Low-Grade Glioma (pLGG) vor 1 Jahr 8:55
19. Navigating The Complexity of Melanoma Care: Part 6 vor 1 Jahr 2:01
20. Navigating The Complexity of Melanoma Care: Part 5 vor 1 Jahr 1:35
21. Navigating The Complexity of Melanoma Care: Part 4 vor 1 Jahr 2:40
22. Navigating The Complexity of Melanoma Care: Part 3 vor 1 Jahr 1:15
23. Navigating The Complexity of Melanoma Care: Part 2 vor 1 Jahr 2:16
24. Navigating The Complexity of Melanoma Care: Part 1 vor 1 Jahr 2:46
25. Community Education Program Improves Patient Education and Cancer Screening Rates vor 1 Jahr 7:01
26. Cholangioscopy: What Interventional Oncologists Need to Know Part 2 vor 2 Jahren 46:05
27. Cholangioscopy: What Interventional Oncologists Need to Know vor 2 Jahren 41:01
28. Applications of AR in Interventional Oncology vor 2 Jahren 11:45
29. How Artificial Intelligence May Change Interventional Oncology vor 3 Jahren 26:30
30. Sacituzumab Govitecan Plus Pembrolizumab in the TROPHY-U-01 Trial vor 3 Jahren 7:31
31. Episode 1: Maintenance Rituximab for Waldenström Macroglobulinemia vor 3 Jahren 26:10
32. Neoadjuvant Chemotherapy Plus HER2-Targeted Therapy for Early Stage HER2-Positive Breast Cancer vor 4 Jahren 7:17
33. Advances in Gastrointestinal Genetic Testing vor 4 Jahren 4:51
34. Enfortumab Vedotin for Metastatic Urothelial Cancer After Progression on Platinum-Based Chemotherapy vor 4 Jahren 6:58
35. BRCAness May Predict Response to Platinum-Based Chemotherapy in Intrahepatic Cholangiocarcinoma vor 4 Jahren 7:33
36. Durvalumab Conveys Benefit for All Biliary Tract Cancer Types vor 4 Jahren 5:29
37. Pemigatinib for Cholangiocarcinoma with FGFR2 Fusions or Rearrangements vor 4 Jahren 4:32
38. Maintenance Cabozantinib in Metastatic Urothelial Carcinoma vor 4 Jahren 4:51
39. Sacituzumab Govitecan Plus Pembrolizumab for Platinum-Refractory Metastatic Urothelial Cancer vor 4 Jahren 8:45
40. Part 2: Overcoming PARP Inhibitor and Platinum Resistance in Patients With Ovarian Cancer vor 4 Jahren 7:06
41. Part 1: Current Emerging Therapies for Platinum-Resistant Ovarian Malignancies With Dr O'Mally vor 4 Jahren 9:48
42. Therapeutic Advances and Considerations for Treatment Selection in High-Risk AML vor 5 Jahren 25:00
43. Ibrutinib Improves Outcomes Over Rituximab Among Patients With Advanced CLL/SLL vor 5 Jahren 8:40
44. Evolving Roles of KRAS Inhibitors in CRC vor 5 Jahren 1:45
45. The Role of Tumor Mutation Burden Featuring Dr Morris vor 5 Jahren 0:50
46. Dr Morris Discusses Emerging Targeted Therapies in mCRC vor 5 Jahren 3:02
47. Dr Lieu Talks ctDNA to Guide CRC Treatment vor 5 Jahren 3:15
48. Dr Casulo Overviews Approved Treatment Options to Manage Newly Diagnosed, Relapsed FL vor 5 Jahren 5:20
49. Dr Batlevi Shares Promising Data of Tazemetostat from SYMPHONY-1 Trial vor 5 Jahren 4:46
50. Dr Loprinzi Reviews Hot Flash Treatment Strategies in BC, Part II vor 5 Jahren 0:19